null

Tezepelumab (Anti-TSLP) Biosimilar Antibody

SKU:
HDBS0111
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
TSLP
Reactivity:
Human
Host Species:
Human
Isotype:
IgG2
€373
Frequently bought together:

Description

system_update_altDatasheet

Tezepelumab (Anti-TSLP) Biosimilar Antibody (HDBS0111)

The Tezepelumab Biosimilar Anti-TSLP Antibody is a cutting-edge research tool designed for studying thymic stromal lymphopoietin (TSLP), a key regulator of allergic inflammation. This antibody, developed for use in various research applications, is highly specific and reacts with TSLP in human samples with high sensitivity.Thymic stromal lymphopoietin (TSLP) is a cytokine that plays a crucial role in initiating and driving allergic inflammatory responses in conditions such as asthma, eczema, and allergic rhinitis. By targeting TSLP, researchers can gain valuable insights into the mechanisms underlying these diseases and potentially develop new therapies to treat them.

The Tezepelumab Biosimilar Anti-TSLP Antibody opens up new possibilities for studying the role of TSLP in allergic inflammation and developing innovative treatments to improve the lives of individuals affected by allergic diseases. Its high specificity and sensitivity make it a powerful tool for advancing research in immunology, respiratory medicine, and drug development. Unlock the potential of TSLP research with this cutting-edge antibody.